October Capital
VC Fund
Kansas City, United States
October Capital is a family investment firm that finances early and growth stage ventures.
- Total investments:
- 13
- Last investment:
- Lead investor:
- 31%
Last updated:
For AI agents: llms.txt
Industries October Capital invests in
Stages October Capital invests in
Countries October Capital invests in
Investment Focus
Industry
- Biotechnology 4 (31%)
- Medical 3 (23%)
- Health Care 3 (23%)
- Manufacturing 3 (23%)
- Life Science 2 (15%)
Stage
- Series B 4 (31%)
- Series A 2 (15%)
- Series C 2 (15%)
- Funding Round 2 (15%)
- Series E 1 (8%)
Country
- China 10 (77%)
- United States 3 (23%)
Investments
| Company | Description | Round | Links |
|---|---|---|---|
Bang Er Orthopedic
|
Zhejiang Boner Medical Investment Management Co., Ltd. is a well-known professional hospital investment operator in the Yangtze River Delta, featuring major orthopaedics and rehabilitation. | $109.8M / Series E / Nov 09, 2023 | |
Super Years
|
Super Years is a gene technology company that focuses on the research, development, and manufacturing of high-end life science instruments. | $8.2M / Series A / Sep 24, 2023 | |
Epintek
|
Epintek is a one-stop service platform for medical equipment. | Series C / Aug 28, 2023 | |
Bostal Drug Delivery
|
Bostal Drug Delivery develops and manufactures drug preparation products for new drug delivery systems. The company provides pharmaceutical preparation technology platforms to develop innovative drugs, improve new drugs, and high-end generic drugs. It also offers preparation products technical development services for pharmaceutical companies.Thecompany was founded in 2013 and is headquartered in Guangzhou, Guangdong. | Series B / Aug 18, 2023 | |
Nuclei System Technology
|
A notable feature of the RISC-V architecture is its open scalability to facilitate the special needs of specialized areas. It is embodied in the instruction code space and the predefined Custom command, which is convenient for specific functions such as security or intelligent acceleration under the unified development model to make the productmore competitive. Nuclei System Technology provides customers with RISC-V related training services with the most professional technology, instruction set expansion and acceleration module design services based on core RISC-V processor IP, and dedicated high performance and low power processor design services. | Venture - Series Unknown / Aug 01, 2023 | |
Anjielai Technology
|
Anjielai Technology is a developer of artificial intelligence exoskeleton robots. | Private Equity / Jan 01, 2023 | |
Atech Automotive Electronics
|
Atech Automotive Electronics is a company that designs, develops, manufactures and sells various automotive electronic products | $69M / Series C / Nov 08, 2022 | |
Baiying Bio
|
Baiying Bio offers economic recombinant protein and antibody reagents and is a CRO vendor for life science researchers and biopharma companies. They provide services including HTP recombinant antibody and VHH production, bispecific antibody production, antibody humanization, VHH library generation, hybridoma sequencing, protein expression inmammalian cells, large-scale antibody production, and more. They delivered tens of thousands of recombinant antibodies to customers. | $72.6M / Series B / Aug 31, 2022 | |
Biointron
|
Biointron is committed to providing high-quality and economic recombinant protein/antibody reagents. The company was founded in 2012 and is headquartered in Shanghai, China. | $72.6M / Series B / Aug 31, 2022 | |
Ling Yan Technology
|
Ling Yan Technology offers integrated information and communication technology (ICT) solutions. | Series A / Oct 22, 2021 | |
| See all 13 investments → | |||
Co-Investors
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Similar stage
Similar country
Featured in Investor Lists
Recommended lists
FAQ
What does October Capital invest in?
October Capital invests primarily in Biotechnology, Medical and Health Care startups, most often at Series B and Series A stage. Most of the 13 investments tracked by Shizune back companies in China. The Investment Focus section breaks down every industry, stage and country in the portfolio.
When did October Capital last invest?
The most recent investment recorded for October Capital closed in Nov 2023. Shizune tracks 13 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
